Benitec Biopharma (BNTC) Total Liabilities (2019 - 2025)
Benitec Biopharma (BNTC) posted Total Liabilities of $3.3 million for Q4 2025, up 36.74% sequentially from $2.4 million in Q3 2025.
Benitec Biopharma (BNTC) Total Liabilities (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Total Liabilities for 7 years, with the latest figure at $3.3 million in Q4 2025.
- Quarterly Total Liabilities changed N/A year-over-year to $3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, down 53.71% from the prior year.
- Total Liabilities rose to $3.3 million in Q4 2025 per BNTC's latest filing, from $2.4 million in the prior quarter.
- Over five years, Total Liabilities peaked at $7.6 million in Q1 2025 and troughed at $1.4 million in Q2 2021.
- A 5-year average of $3.6 million and a median of $3.3 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities jumped 258.29% in 2021, then slumped 53.71% in 2025.
- Over 5 years, Total Liabilities stood at $3.2 million in 2021, then fell by 8.4% to $2.9 million in 2022, then soared by 102.1% to $5.9 million in 2023, then slipped by 21.91% to $4.6 million in 2024, then fell by 27.73% to $3.3 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $3.3 million, $2.4 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.30 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 3.50 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 2.54 Mn |
| Dec 31, 2021 | 3.18 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 1.37 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 887,000.00 |